Introduction
Development of neoplastic cells in the mammals is suppressed by host factors that can exert either an antitumor eect directly on the transformed cells or that can indirectly promote the attack of the cells of immune system. In both the scenarios, cytokines play a crucial role. Among the cytokines, the Interferon (IFN) group of cytokines can exert direct and indirect antitumor eects on the tumor cells. IFNs induce the expression of a number of cellular genes employing the Janus kinase ± Signal transducing activator of transcription (JAK ± STAT) pathway to exert their eects (Darnell et al., 1994) . A central role for IFNs in neoplastic cell growth control was highlighted by observations such as the increased incidence of carcinogen-induced tumors in the IFN-g receptor 7/7 and STAT1 7/7 mice, and a failure to reject the STAT1 null tumors by the immune system (Kaplan et al., 1998) . Mutational inactivation of some IFN-regulated factor genes, such as IRF-1 and ICSBP (IFNconsensus sequence binding protein), has been implicated in the loss of apoptotic functions and development of myeloid leukemias (Holtschke et al., 1996; Taniguchi et al., 1997) . IFNs also activate growth suppressive transcription factors such as pRb (Resnitzky et al., 1992) and down regulate c-myc, E2F and cyclin D3 in certain lymphoid tumor cell lines (Raveh et al., 1996; Tiefenbrun et al., 1996) . Since IFNs are marginally active in the therapy of solid tumors, a number of combination therapies with IFNs were developed (Gutterman, 1994) . Among these, the IFN and retinoid combination is highly eective against several tumors in clinical and experimental models .
Retinoids are vitamin A-like molecules, which induce the expression of genes involved in dierentiation, growth control and metabolism using speci®c nuclear receptors (Mangelsdorf and Evans, 1995) . Long-term deprivation of vitamin A to laboratory animals results in the development of a number of carcinomas and leukemias (Love and Gudas, 1994) and an abnormal rise in myelopoiesis owing to a loss of spontaneous apoptosis (Kuwata et al., 2000) . All trans Retinoic Acid (RA), a prototypic retinoid, can either suppress or reverse these eects in vivo. Two structurally similar but genetically distinct transcription factors, the retinoic acid receptor (RAR) and the retinoid X receptor (RXR) induce the expression of genes involved in growth suppression (Glass et al., 1997) . A number of RAR and RXR isoforms appear to mediate this complex process. Based on this, several synthetic retinoids that can dierentially activate these receptors have been identi®ed. These synthetic retinoids suppress cell growth via both RAR-RXR dependent and independent mechanisms (Lotan, 1996; Nagy et al., 1998) . Some synthetic retinoids induce cell death in p53 dependent or independent manners (Sun et al., 1999b (Sun et al., , 2000 . Other synthetic retinoids activate the translocation of orphan nuclear receptor TR3 from the nucleus to mitochondrion to activate apoptosis (Li et al., 2000) . Finally, the anti-apoptotic protein BAG-1 interferes with RAR-RXR dependent transcription leading to a possible resistance to retinoid-induced apoptosis (Liu et al., 1998) .
We have shown earlier that the IFN/RA combination, but not single agents, causes cell death in vitro and suppresses tumor growth in vivo (Lindner et al., 1997) . To understand the mechanisms of IFN/RA stimulated cell death we have employed the antisense technical knockout approach (Deiss and Kimchi, 1991) and identi®ed several Genes associated with Retinoid-IFN induced Mortality (GRIM) (Hofmann et al., 1998) . In this approach speci®c death-associated genes are identi®ed by their ability to confer growth advantage to cells in the presence of death inducer, when expressed in an antisense orientation. One such gene, GRIM-12 was identi®ed as the redox enzyme, thioredoxin reductase (TR) (Hofmann et al., 1998) . Down regulation of TR expression by its antisense mRNA inhibited IFN/RA stimulated cell death. Conversely, overexpression of TR enhanced the cellular sensitivity to IFN/RA stimulated death. Here we show that the tumor suppressing transcription factor p53 is a target of redox modulation, and TR and its substrate thioredoxin 1 (Trx1) are necessary for this process. The IFN/RA combination stimulates the transcriptional activity of p53 without increasing the p53 levels. These studies identify a novel mechanism of p53-induced gene expression.
Results

Thioredoxin reductase is necessary for IFN/RA-induced cell death
As said earlier the redox enzyme TR was isolated as a death regulator using a genetic approach (Hofmann et al., 1998) . To understand the functional relevance of TR to cell death we have generated a mutant enzyme lacking the critical cysteine residues at its active site. The mutant and wild type TR cDNAs were cloned into a mammalian expression vector, pCXN2-myc, which permits the addition of a c-terminal myc epitope tag to the expressed protein. These constructs or the expression vector alone were transfected separately into MCF-7 cells to generate stable transfectants. Interestingly, transfection of wild type TR yielded signi®cantly fewer (33%) stable colonies compared to the vector transfected cells, consistent with its cytotoxic property (data not shown and Hofmann et al., 1998) . In the following studies, pools of clones (*150) expressing various constructs were used. The expression of TR or its mutant was con®rmed by Western blot analysis of cell extracts with anti-myc epitope speci®c antibodies ( Figure 1a ). These antibodies detected no band in vector-transfected cells because the Tag protein is too small to be retained on the gel. In the case of wild type and Cys-mut transfected cells a predicted size protein (*61 kDa) is expressed as detected by anti-myc epitope antibodies. We have consistently observed a 3 ± 4-fold lower expression of the wild type protein than the mutant protein. To determine whether the expression of endogenous TR protein was altered following expression of myc-tagged recombinant TR proteins in the cells, these extracts were separated on a 14% SDS-polyacrylamide gel subjected to Western blot analysis with TR speci®c antibodies. Since the size dierence between the transgene derived endogenous protein was smaller (*3 kDa), the gel was run for longer time to resolve the bands ( Figure 1b) . As expected, a single band of TR1 (*58 kDa) was seen in the vector-transfected cells. In the wild type and Cys mut transfected cell extracts a slow moving band corresponding to the transgene derived TR was also detected, in addition to the endogenous protein.
Densitometric quanti®cation revealed no signi®cant dierence in the expression of endogenous TR1 between various transfectants (Figure 1c) .
To distinguish the dierences between the death sensitivities of these cells, they were exposed to IFN/ RA and then stained with FITC-annexin-V to detect apoptotic cells (Figure 1d ). Although no signi®cant cell death could be detected without any treatment, IFN/ RA caused a strong increase in the number of dead cells. More importantly, a signi®cantly higher per cent of wild type TR transfected cells were annexin-V positive than the vector transfected ones. In contrast, cell death was strongly inhibited in the Cys mut expressing cells, as revealed by a signi®cantly lower yield of annexin-V positive cells. These data suggest that wild type TR is necessary for mediating cell death in response to IFN/RA. Similar results were obtained with Trypan blue staining of cells (data not shown).
The eect of TR overexpression on cell survival was also determined using a transient transfection assay. MCF-7 cells were transfected with CMV-b-galactosidase and the expression vectors for the wild type or Cys mut. Three days after transfection, cells were stained with X-gal to determine the percentage of dead cells. Blue colored cells with a normal epithelial morphology were considered live and those with a rounded appearance were considered dead. The percentage of cell death was determined from the ratio of dead blue cells to the total blue cells. Consistent with above data, transfection of wild type TR, but not the Cys mut, caused a threefold increase in cell death (Figure 1e ). Vector alone did not cause signi®cant cell death. Although the percentage of cell death was smaller it was distinctly dierent from the controls (compare bars 1 and 2).
The apoptotic nature of TR induced cell death was con®rmed using a dierent approach. Three days after the transfection of various plasmids, cells were stained with FITC-annexin-V to detect the dead cells ( Figure 1f ). Although the percentage of annexin positive cells was small in this study a signi®cant dierence between the vector, wild type and Cys mut transfected cells was detected. Relatively, a 3 ± 3.5-fold more cells were annexin-V positive in the wild type TR transfected cultures than those with vector alone. The Cys mut transfected cultures did not yield any higher annexin-V positive cells than the vector transfected ones. In these experiments, the percentage of annexin-V positive cells is relatively smaller because it is a transient transfection and the percentage is calculated on the basis of total number of cells (transfected and untransfected) in the plate. In addition, the TR dependent cytotoxic eects were blocked in the presence of caspase inhibitors, indicating the apoptotic nature of cell death (Ma et al., 2001 , in press). Thus, TR is a death promoter.
Over expression of TR promotes cell death
Since our earlier studies identi®ed TR as a death promoter (Hofmann et al., 1998) and some yeast mutants lacking TR failed to support the growth suppressive eects of human p53 (Casso and Beach, 1996; Pearson and Merrill, 1998) , we next determined whether TR dependent apoptotic eects are mediated through the p53 protein. MCF-7 cells were transfected with human p53 expression vector in the presence or absence of wild type or mutant TR constructs. Along with these constructs the CMV-galactosidase reporter plasmid was coexpressed to track the transfected cells. Two days later cells were stained with X-gal to detect the transfected cells. Blue colored round cells (dead) were expressed as a per cent of total blue colored cells. As shown in Figure 2a transfection of vector or Cys mut alone did not cause signi®cant death. In contrast, wild type TR induced a threefold more cell death than the vector. Transfection of p53 alone caused a fourfold increase in cell death under these experimental conditions. In the presence of TR, p53 stimulated death was augmented 11-fold compared the vector. In contrast, the Cys mut blocked p53-induced cell death, yielding only a twofold increase. These data show that TR augments p53-dependent death.
To con®rm the apoptotic nature of cell death annexin-V staining was performed on the transfected cells. After transient transfection of various plasmids, cells were cultured for 72 h and then stained with annexin-V. The percentage of annexin-V positive cells was determined using FACS. Consistent with the data in Figure 2a , transfection of wild type p53 or wild type TR signi®cantly increased cell death compared to the vector alone (Figure 2b ). Cotransfection of wild type TR and p53 caused a synergistic increase in the per cent of annexin-V positive cells. The Cys-mut blocked p53 dependent death, as revealed by fewer annexin-V positive cells compared to the controls. The per cent of annexin-V positive cells is relatively smaller because it is a transient transfection experiment and percentage is calculated on the basis of total number of cells (transfected and untransfected) in the plate, unlike the one in Figure 2a . Lastly, the methods of scoring in Figure 2 Eect of TR on p53 induced cell death. Expression vector for wild type p53 (1 mg) and CMV-b-galactosidase (0.5 mg) were transfected into MCF-7 cells. Speci®c eector plasmids (1 mg), indicated on the X-axis, were co-expressed to determine their eects on p53 induced cell death. Cells were stained using the in situ b-galactosidase kit to identify the transfected cells 72 h later. Round blue cells (dead) were expressed as a per cent of total blue cells. Background death due to transfection was subtracted from these values. This was determined by performing a control transfection with CMV-b-galactosidase (0.5 mg) and pBluescript (2 mg). Although the IFN-b/RA combination causes the death of several dierent tumor cell lines, the concentration of these drugs required for inducing death was variable. Notably, a lower concentration of IFN/RA was sucient for inducing death in cell lines that have a wild type p53 than those with a mutant p53 or dysfunctional p53. For example, MCF-7 cells, which have a wild type p53 (Balcer-Kubiczek et al., 1995) can be readily killed at IFN-b (500 U/ml) and RA (1 mM), whereas HeLa cells, which have a dysfunctional p53 due to endogenous HPV-E6 (Schener et al., 1990) , required nearly IFN-b (3000 U/ml) and RA (5 mM). Although these observations suggest that IFN/RAinduced death can occur independent of p53, presence of a wild type p53 can enhance sensitivity to death. Therefore, the signi®cance of p53 in a TR dependent death pathway was tested using the MCF-7 cells stably transfected with human papilloma viral E6 gene (Fan et al., 1995) . Previously, the expression of this protein has been shown to abrogate the p53 dependent cellular damage responses (Fan et al., 1995; Kessis et al., 1993; Potapova et al., 2000) . A transient transfection assay similar to the one in Figure 2a was performed using various TR mutants in cells expressing transfection vector (MCF-7 neo) or the E6 protein (MCF-7 E6). Consistent with the data in Figures 1 and 2a , the wild type TR but not the Cys mut, caused a dramatic increase in the number of dead cells in the MCF-7 neo culture ( Figure 2c ). TR induced cell death was signi®cantly inhibited in cells expressing the E6 protein.
However, a small but signi®cant death continued to occur in these cells. This observation indicates the existence of other TR mediated-p53 independent cell death pathways.
Next, we have examined the dierential death sensitivities of MCF-7 neo and MCF-7 E6 cells in response to IFN/RA using annexin-V. The percentage of annexin-V positive cells was determined using FACS analysis. Although IFN/RA treatment increased the annexin positive cells in both cases, signi®cantly higher percentage of MCF-7 neo cells were stained with annexin than MCF-7 E6 cells ( Figure 2d ). In sum, the presence of a functional p53 clearly enhances cellular sensitivity to IFN/RA induced death.
IFN/RA does not increase the levels of tumor suppressor p53
Since several exogenous agents cause an increase in the physical levels of p53 protein (Vogelstein et al., 2000) and p53 inactivation by HPV-E6 signi®cantly suppresses cell death (Figure 2c,d) , we have examined whether IFN/RA treatment enhanced levels of p53 protein in the cells. Whole cell extracts were prepared after various treatments and Western blot analysis was performed using a monoclonal antibody that can speci®cally detect wild type p53. As shown in Figure  3a , p53 levels remained unchanged with IFN-b, RA and IFN/RA treatment. Lack of an elevation of p53 levels was not due to a generalized defect in these cells because ionizing radiation strongly induced it. These blots were also reprobed with monoclonal antibody against actin to ensure the presence of comparable amounts of protein in all the lanes. Similarly, exposure of cells to IFN/RA combination for longer periods of time also did not cause an increase in the p53 levels ( Figure 3b ). Thus, IFN/RA does not appear to enhance the p53 protein levels during cell death.
IFN/RA promotes p53 dependent death by augmenting the expression of p53 inducible genes
Since TR augments both p53 dependent and IFN/RA stimulated death, we have examined the in¯uence of IFN/RA on the p53 dependent gene expression. For this purpose three dierent cell lines each expressing either the vector, wild type TR or Cys mut ( Figure 1 ) were employed. Cells were exposed to the IFN/RA combination for 12 and 24 h, RNA was extracted and a comparable amount of total RNA from each cell line was Northern blotted. These blots were probed with a battery of p53-inducible genes (Figure 4a ). These included p21/Waf/Cip1, a cell cycle inhibitor (el-Deiry Where indicated with irrad' cells were exposed to 2 Gy of radiation in a cesium irradiator. Equal amount of whole cell extract (100 mg) was employed in Western blot analysis, after separating on a 10% SDS ± PAGE. The blots were probed with a monoclonal antibody speci®c for p53. Subsequently, these blots were also stripped and reprobed with antibodies speci®c for actin. (b) cells were exposed to the IFN/RA for the indicated number of hours prior to the extraction of protein and use in Western blot analyses et al., 1993), Bax, an apoptosis-inducing member of the Bcl2-family of proteins (Miyashita and Reed, 1995) , and three p53-inducible genes, PIG3, PIG6, and PIG12 (Polyak et al., 1997) . In each case the expression of speci®c mRNAs was quanti®ed from dierent blots and was presented in panel b. Although Waf-1 is mildly induced by IFN/RA in the vector-transfected cells (threefold), its expression was strongly augmented (5 ± 6-fold) in cells overexpressing wild type TR ( Figure  4a,b) . The expression of Waf-1 mRNA was sustained at 24 h post-treatment in the wild type TR transfected cells, in contrast to the vector-transfected cells where it was down regulated. IFN/RA stimulated Waf-1 mRNA induction was ablated in the presence of Cys mut. In a similar manner, PIG3, PIG6 and PIG12 mRNAs were strongly induced by IFN/RA in the wild . Although a basal level of Bax mRNA was found in Cys mut expressing cells, it was not further induced by IFN/RA. All these lanes had a comparable amount of RNA as detected by the GAPDH probe, indicating a speci®c eect of TR and IFN/RA on p53-regulated genes. Since all these experiments used pools of colonies (*150 colonies) it does not represent a clonal eect. Thus, p53 mediated gene expression is stimulated by IFN/RA through TR.
Since IFN/RA promotes p53 dependent gene expression, we have studied whether it results in the expression of any of these proteins. We have chosen Bax for this study because it is a known death promoter. Vector, wild type and Cys mut expressing cells were exposed to IFN/RA combination and the lysates were Western blotted using Bax speci®c antibodies (Figure 4c ). Figure  4d shows the quanti®cation of Bax protein released in to the cytosol. Consistent with the Northern blot data IFN/RA induced the expression of Bax protein in the vector (threefold) and wild type TR (*sevenfold) expressing cells. However, no such induction of Bax protein by IFN/RA was noticed in the Cys mut expressing cells. One consequence of increased Bax expression is the release of cytochrome c from mitochondrion, which promotes apoptosis via caspase-9 activation (Gross et al., 1998) . Therefore, postmitochondrial cytosolic fractions were examined for the release of cytochrome c. In agreement with the Bax Western data an increased level of cytochrome c was found in the cytosolic fraction of IFN/RA treated vector and wild type TR expressing cells but not in those expressing the Cys mut. No change in the p53 protein levels occurred whether or not the cells were treated with IFN/RA. Western blotting with actin speci®c antibodies revealed the presence of comparable amount of protein in all the lanes. IFN/RA promotes the transcription of p53 dependent genes via TR Based on the above results, we next determined the step at which IFN/RA combination or TR aects the p53-dependent genes. For this purpose the Waf-1 promoter driven luciferase reporter, Waf1-Luc, was used as a representative p53 stimulated gene. This plasmid was transfected into MCF-7 cells and then exposed to IFN/RA combination. As shown in Figure  5a , IFN/RA caused a threefold increase in luciferase expression compared to the untreated control. Neither IFN-b nor RA alone induced the luciferase activity. Thus, IFN/RA stimulates the expression of p53-inducible genes at a transcriptional level. The importance of p53-binding site for the induction of luciferase activity was studied using the deletion mutants of Waf-1 promoter in a separate experiment.
Cells were transfected with three dierent luciferase reporter constructs, which possessed various lengths of Waf-1 promoter. Two p53-binding sites are present in 72326 construct (Somasundaram et al., 1997) . The other two reporters, 7173 and 793 that lacked these sites, were not induced by the IFN/RA combination (Figure 5b) . We next examined the in¯uence of wild type or Cys mut on Waf1-Luc expression (Figure 5c ). Cotransfection of wild type TR enhanced luciferase gene expression compared to the vector. As expected the Cys mut blocked the luciferase gene expression. Treatment of vector-transfected cells with IFN/RA induced the gene expression, which was further augmented in the presence of wild type TR. However, the Cys mut suppressed IFN/RA stimulated luciferase expression from the Waf-1 promoter.
In the light of above observations, the in¯uence of TR mutants on p53 dependent gene expression was studied. Cells were transfected with the Waf-1 promoter and wild type p53. Along with these plasmids either the empty, wild type TR or Cys mut expression vector were also transfected and their in¯uence on luciferase gene expression was measured. In each case a control without p53 transfection was also performed (Figure 5d ). As anticipated, wild type TR alone induced the basal expression and the Cys mut suppressed it. Although these numbers are hard to visualize because of the size of y-axis, these dierences could be seen in Figure 5c . Transfection of p53 expression vector strongly induced luciferase gene expression. However, in the presence of wild type TR the gene expression was signi®cantly stimulated further. The Cys mut suppressed the p53-dependent luciferase expression, yielding a fourfold lesser luciferase activity. Taken together, these data indicate that TR can promote p53-dependent gene expression in response to IFN/RA.
The transcriptional stimulatory activity of TR on p53-inducible genes in the presence of IFN/RA was also con®rmed using another p53 responsive luciferase reporter, the Bax-Luc, driven by the human Bax promoter. MCF-7 cells were transfected with Bax-Luc and wild type or mutant TR gene (Figure 5e ). Luciferase activity was strongly induced upon IFN/ RA treatment. However, in the presence of wild type TR, Bax promoter was signi®cantly induced yielding a 17-fold more luciferase activity, compared to the untreated cells. This stimulation was signi®cantly more than the IFN/RA-treated vector cotransfected control. In contrast a signi®cant suppression of luciferase activity was noted in the presence of the Cys mut.
A direct eect of Trx1 on p53 dependent gene expression was analysed using luciferase reporter genes containing consensus wild type or mutant p53 binding sites cloned upstream of the SV40 early promoter in pGL3 promoter vector (Figure 5f ). Along with these plasmids a wild type Trx1 expression vector was transfected to determine its eect on p53 dependent gene expression. The reporter bearing wild type p53 responsive element (p53RE) was slightly stimulated (1.8-fold) by Trx1. Transfection of p53 strongly (threefold) induced the luciferase gene expression, which was further signi®cantly stimulated in the presence of wild type Trx1. No such stimulatory eect of either Trx1 or p53 was observed when a similar experiment was performed using a reporter driven by a mutant p53-binding site.
Lastly, an obligatory role for p53 in mediating TR and Trx1 stimulated transcriptional response through the p53RE was demonstrated using MCF-7 neo and MCF-7 E6 cells (Figure 5g ). In these experiments a wild type p53RE-luciferase was transfected into the cells along with wild type TR, wild type Trx1, redox inactive Trx1 or their combination. Wild type TR and Trx1 alone stimulated the luciferase activity *2 ± 2.1-fold in the MCF-7 neo cells. Their combination synergistically enhanced the transcription further. Consistent with an obligatory role of Trx1 in this process, mutant Trx1 was unable to exert the synergistic eect on the luciferase expression in the presence of wild type TR. No such signi®cant stimulatory eects of TR, Trx1 or their combination on p53RE driven luciferase gene expression were obvious in MCF-7 E6 cells, indicating the fact that these responses require not only TR, Trx1 but also a functional p53.
Effect of TR and Trx on p53-dependent gene expression
Because MCF-7 cells contain the endogenous wild type p53 (Balcer-Kubiczek et al., 1995) it is dicult to distinguish whether the transcriptional stimulatory eect of TR on p53 was due to its eect on the endogenous or the transfected p53. For this purpose mouse embryo ®broblasts (between 18 ± 26 passages) lacking the p53 gene (p53
) were used in the following studies. These cells were transfected with the Waf-1-Luc along with an empty, wild type, or a mutant p53 expression vector. As expected, only wild type p53 but not a mutant p53 was able to stimulate transcription (Figure 6a ). In the next experiment, the reporter gene was cotransfected with an empty or the human Trx1 (a known substrate of TR) expression vector into p53 7/7 ®broblasts. In the absence of p53, Trx1 did not induce the expression of luciferase activity, consistent with the requirement of p53. The mutant p53 failed to induce transcription even though wild type Trx1 was present. In contrast transfection of a wild type p53 upregulated the luciferase activity, which was signi®cantly augmented further in the To further prove that a redox active Trx1 was critical for augmenting p53 dependent gene expression p53 7/7 ®broblasts were transfected with a wild type p53 along with either wild type or mutant Trx1 expression vectors (Figure 6c) MEFs did not alter signi®cantly, although some studies showed that a p53 de®ciency leads to polyploidy in the cells (Di Leonardo et al., 1997; Tsukada et al., 1993) . In a dierent experiment, Waf1-Luc construct was transfected along with wild type or mutant p53 in the presence or absence of Trx1 into wild type murine ®broblasts (Figure 6d ). Trx1 alone caused a twofold increase in luciferase activity. However, it did not promote luciferase expression in the presence of mutant p53. As expected, wild type p53 caused a strong upregulation of transcription, which was further enhanced in the presence of Trx1. A similar experiment was repeated in MCF-7 cells and the luciferase induction patterns were very similar (Figure 6e) .
We next examined the in¯uence of TR on p53 dependent gene expression in p53 7/7 ®broblasts ( Figure  6f) . Cotransfection of empty, wild type TR or Cys mut expression vector with Waf1-Luc had no signi®cant eect on the luciferase expression. As expected p53 strongly stimulated the luciferase gene expression, which was signi®cantly enhanced further in the presence of wild type TR. On the other hand, the Cys mut downregulated gene expression as evidenced by a lower luciferase activity than the vector control.
To demonstrate a direct relationship between TR and Trx1 in promoting p53 dependent gene expression. Waf1-Luc vector was transfected along with wild type or mutant Trx1 in the presence or absence of wild type TR or Cys mut into p53 7/7 ®broblasts (Figure 6g) . In all the cases a wild type p53 expression vector was included. Wild type TR strongly promoted the luciferase gene expression in the presence of wild type Trx1, but not mutant Trx1. Similarly, wild type Trx1 was unable to enhance luciferase gene expression in the 7/7 ®broblasts. Various indicated plasmids were transfected along with Waf1-Luc. Luciferase activity was measured 24 h after transfection as described in Materials and methods. (h) Eect of Trx1 on a luciferase reporter driven by the minimal p53 responsive element. The indicated plasmids were transfected and luciferase activity was measured as above presence of Cys mut. As anticipated, the Cys mut and the mutant Trx1 together could not augment luciferase gene expression. These data indicate the importance of TR and Trx in p53 regulated gene expression.
The p53 dependent gene stimulatory eects of Trx1 through the minimal p53RE were examined next in p53 7/7 cells. Cells were transfected with a luciferase reporter driven by the wild type p53RE (same as in Figure 5f ) along with a wild type or mutant p53 expression vector. These experiments were conducted in the absence or presence of a Trx1 expression vector ( Figure 6h ). As expected transfection of Trx1 expression vector alone did not stimulate the reporter in the absence of p53. Similarly, mutant p53 did not stimulate luciferase activity and wild type Trx1 had no eect on it. However, transfection of wild type p53 induced the luciferase activity 2.5 ± 3-fold. Such activation was further induced signi®cantly in the presence of Trx1. Thus, Trx1-dependent gene stimulatory eects are mediated through the p53RE and require a functional p53.
IFN/RA induced DNA binding of p53 Since IFN/RA promotes the p53 dependent transcription through TR we have determined the in¯uence of TR on the DNA binding of p53 using an electrophoretic mobility shift assay (EMSA). In the ®rst set of experiments, the in¯uence of IFN/RA on the binding of p53 to its response element was determined. Nuclear extracts were prepared from MCF-7 cells treated with IFN-b (500 U/ml), RA (1 mM) or their combination. They were incubated with a double stranded 32 P-labeled oligonucleotide consisting of the consensus p53 binding site (Figure 7a ). Neither IFN-b (lane 2) nor RA (lane 3) induced a detectable binding of p53 to the probe. However, consistent with the death phenotype, IFN/ RA combination readily induced the DNA binding of p53 (lane 4). In the next experiment, the eect of TR mutants on IFN/RA-induced DNA binding of p53 was investigated ( Figure 7b ). As expected, no binding of p53 to the oligonucleotide was observed in the untreated cells (lanes 2, 4 and 6). However, IFN/RA treatment strongly induced the DNA binding of p53 in the vector and wild type expressing cells (Figure 7b,  lanes 3 and 5) . However, no such induction of p53 binding to the response element was observed in the Cys mut expressing cells (lane 7). More importantly, there was a threefold higher DNA binding of p53 in the wild type TR expressing cells than in those expressing an empty vector. We next examined whether the dierence in DNA binding between the cells was due to dierent amount of p53 in the nuclear extracts. Nuclear extracts of IFN/RA treated empty, wild type and Cys mut TR vector expressing cells were Western blotted using an antibody against p53 (Figure 7c) . No signi®cant dierence in the nuclear p53 levels was noted between the MCF-7 cell lines expressing various TR mutants.
The speci®city of p53 DNA binding was con®rmed by performing competition assays with oligonucleotides bearing the wild type and mutant p53 binding sites. As (7) or IFN/RA (+) for 12 h prior to the preparation of nuclear extracts. Equal quantity of nuclear extract (10 mg) was used in an EMSA with 32 P-labeled p53-binding element as a probe. The DNA bound p53 complex is indicated with an arrow. Speci®c cell lines used as source of nuclear extract were indicated above the arrow. (c) Shows a Western blot analysis of the IFN/RA stimulated nuclear extract (40 mg) of the cell lines indicated above with an anti p53-antibody. (d) Shows the speci®city of the p53 binding to its cognate element. Where indicated IFN/RA-treated nuclear extracts (10 mg), from wild type TR transfected cells, were incubated in the absence or presence of 50-fold molar excess of wild type (wt) or mutant (mut) p53 response elements as competitors. (e) À supershift' analysis of the DNA:protein complex with p53 speci®c antibodies. Nuclear extracts (3 mg) from IFN/RA treated TR expressing cells was pre-incubated in the absence or presence of a p53 speci®c polyclonal antibody (Ab') for 30' at room temperature prior to use in the EMSA. Ab': antibody alone incubated with the probe. Arrow shows the position of the DNA bound p53 complex. SS:`supershifted' p53-DNA complex shown in Figure 7d , only the wild type (lane 4) but not the mutant oligonucleotide (lane 5) competed out the p53 binding to the labeled probe. As anticipated p53 binding to DNA was observed only with the nuclear extract from IFN/RA stimulated cells (lane 3). The presence of p53 in the DNA bound complex was ascertained by the`supershifting' of this band with polyclonal antibodies directed against p53 protein (Figure 5e ). In these experiments nuclear extracts from IFN/RA treated cells was allowed to bind to DNA after pre-incubation with the antibody. Antibody alone did not form any complex (lane 3). As expected, a single complex was formed upon incubation with a labeled oligonucleotide bearing the p53-binding site (lane 2, indicated with an arrow). Preincubation of nuclear extract with the antibody resulted in à supershifting' of the complex (lane 4), indicating the presence of p53 in this complex.
Discussion
Thioredoxin, a ubiquitously expressed redox protein, controls several activities including cell growth, transcription and immune responses (Arner and Holmgren, 2000) . Although several thioredoxin or thioredoxin-like proteins have been described in mammalian cells (Kurooka et al., 1997; Lee et al., 1998; Spyrou et al., 1997) , their physiologic roles have not been clearly understood. The well characterized of these, Trx1, is critical for mammalian development (Matsui et al., 1996) . Thioredoxin also inhibits DNA synthesis in the fertilized Xenopus eggs (Hartman et al., 1993) . The Trx homologue of Drosophila, deadhead, is essential for female meiosis and early embryonic development (Salz et al., 1994) . A ubiquitous enzyme, thioredoxin reductase (TR), controls the redox status of Trx. This gene is now known as TR1 (Arner and Holmgren, 2000) . Recently, two other TR homologues TR2 and TR3 have been described (Lee et al., 1999; Sun et al., 1999a) , which are expressed in a tissue and organelle speci®c manner. However, their speci®c physiologic roles are unclear at this stage. Using a genetic approach we have shown earlier that TR1 is critical for cell death induction by IFN/RA (Hofmann et al., 1998) . Overexpression of moderate levels of TR1 increases the cellular sensitivity to IFN/RA-induced death (Hofmann et al., 1998) . That TR1 exerts growth suppresive functions via apoptosis is also consistent with other studies, which showed that Trx1 augments IFN-g induced cell death (Deiss and Kimchi, 1991) , and certain tumor cells that hyper produce Trx grow poorly (Rubartelli et al., 1995) . Collectively these data indicate that TR1 and Trx1 can regulate cell death in mammalian cells.
Transcription factor, p53, suppresses neoplastic cell growth by preventing the division of cells with damaged DNA or by inducing cell death (Vogelstein et al., 2000) . It is one of the most frequently inactivated genes in several human cancers. Inhibition of p53 by a physical interaction or promotion of its degradation by certain DNA viral proteins and mutational inactivation by carcinogens result in the loss of p53 function, leading to the genomic instability and the progression of tumor cell growth (Vogelstein et al., 2000) . Its activity is controlled by several post-translational mechanisms such as its stability, increase in its levels, phosphorylation by protein kinases, ubiquitination, SUMOlation, acetylation and redox factors (Jayaraman and . We have shown here that the IFN/RA combination promotes p53 dependent gene expression and cell death using TR1 and Trx1. p53 has two cysteines (residues 242 and 176), which along with two histidines coordinate Zn 2+ for DNA binding (Cho et al., 1994; Hainaut and Milner, 1993) . Indeed, oxidation of cysteines in the DNA binding domain of p53 has been shown to inhibit its transcriptional activity (Delphin et al., 1994; Hainaut and Milner, 1993) . Recent studies have shown that redox factor-1 (Ref-1), a down stream eector of TR : Trx system, promotes p53 dependent gene expression and cell death (Gaiddon et al., 1999) . Ref-1 has been suggested to prevent the oxidation of cysteine residues of p53. Indeed, Trx1 augments Ref-1 dependent gene expression through p53 (Ueno et al., 1999) . However, the physiological stimuli that utilize this pathway are unknown. Unlike these studies, we show here that the expression of a number of p53 dependent deathpromoting genes is activated by IFN/RA in the presence of a functional TR. The death promoting and transcriptional activities are suppressed signi®-cantly in the absence of p53 (Figures 2c,d and 5g and  6h) . Conversely, downregulation of physiological levels of TR promotes cell growth in the presence of IFN/ RA. More importantly, we showed that IFN/RA modulates p53 dependent genes without increasing the physical levels of p53. That a wild type TR fails to activate p53 dependent gene expression in the presence of a mutant Trx1, suggests the physiologic importance of the latter in this process. The failure of TR or Trx to promote gene expression in the absence of p53 clearly indicates the obligatory role of p53 in this process, rather than a modulation of gene expression through other transcription factors. Other studies have shown that wild type human p53, but not a cysteine mutant, inhibits cell growth in yeast (Bischo et al., 1992; Epstein et al., 1998) . In TR 7/7 yeast p53 fails to inhibit cell growth and complementation of TR restores p53 functions (Casso and Beach, 1996; Pearson and Merrill, 1998) . Further, tms1, a dehydrogenase suppresses p53 induced growth arrest (Wagner et al., 1993) . These experiments directly show that the function of p53 is dependent on its redox status. Redox regulation of other transcription factors through Trx and Ref-1 has been previously reported. For example, transcription factor activity of AP-1 . Polyoma virus enhancer binding protein 2 (Akamatsu et al., 1997) , hypoxia-inducing factor-1a (Ema et al., 1999) , and NF-kB (Hayashi et al., 1993) is controlled by their redox status. Lastly, evidence that p53 activates Bax and other redox enzymes to mediate death has been presented (Miya-shita and Reed, 1995; Polyak et al., 1997) . Consistent with Bax activation, we have observed the release of cytochrome c, an activator of post-mitochondrial apoptosis (Green and Reed, 1998) . Together with the previous studies, our studies demonstrate a potential link between p53 and IFNs via TR : Trx1.
Materials and methods
Reagents
Restriction and DNA-modifying enzymes (NE Biolabs); G418 Sulphate, IPTG and Lipofectamine plus (Life Technologies); nitrocellulose membranes, ECL reagents and horseradish peroxidase coupled to anti-rabbit or anti mouse antibodies (Amersham-Pharmacia Inc); human IFN-b ser (Berlex Inc.); mouse IFN-b (Pestka Biomedical Labs Inc); mouse monoclonal antibodies against actin (Sigma Inc); p53 (Oncogene Science Inc); and myc-epitope (Zymed Inc); rabbit polyclonal antibodies against cytochrome c (Santa Cruz Biotech Inc) and goat polyclonal antibodies against p53 (Boehringer Mannheim Inc) were employed in these studies. Fresh stocks of all-trans retinoic acid (Sigma) were prepared in ethanol and added to cultures under subdued light.
Cell culture
MCF-7 cells were cultured in phenol red free EMEM supplemented with 5% charcoal stripped fetal bovine serum (CSFBS) and 10 711 M 17b-estradiol during treatment with IFN-b and all trans retinoic acid (RA). Cells were grown in phenol red free media at least 24 h before treatments were initiated. MCF-7 cells stably transfected with mammalian expression vector pCMV-neo (MCF-7 neo) or the same vector with the E6 gene of human papilloma virus type-16 (MCF-7 E6) were provided by AJ Fornace Jr, National Cancer Institute (Bethesda, MD, USA). The loss of p53 function in MCF-7 E6 cells has been demonstrated in earlier reports (Fan et al., 1995; Potapova et al., 2000) . Wild type and p53-de®cient mouse ®broblasts were cultured described previously (Donehower et al., 1992) . These cells were used between the passage numbers 18 ± 26 in various experiments.
Plasmids
Mammalian expression vector carrying the wild type and redox inactive mutant of Trx1 were described elsewhere . In the mutant Trx1 the cysteine residues at positions 32 and 35 were substituted with serines. Wild type and mutant p53 (R175 H) cloned in the pCMV expression vector were described elsewhere (Baker et al., 1990; Kern et al., 1992) . Deletion constructs of Human Waf-1 promoter cloned upstream of the luciferase reporter gene (Somasundaram et al., 1997) were provided by Wa®k elDeiry, University of Pennsylvania (Philadelphia, PA, USA). cDNAs for Waf-1 (el-Deiry et al., 1993), PIG3, PIG6 and PIG12 (Polyak et al., 1997) were provided by Bert Vogelstein and Kenneth Kinzler, Johns Hopkins University School of Medicine (Baltimore, MD, USA). A luciferase reporter driven by human Bax promoter, Bax-Luc (Gaiddon et al., 1999) was provided by Carol Prives, Columbia University (New York, NY, USA). The cDNA for human Bax gene was a gift from Richard Youle, National Institutes of Health (Bethesda, MD, USA) (Nechushtan et al., 1999) . Consensus wild type and mutant p53 binding sites (eight copies) were cloned upstream of SV40 early promoter in the pGL3 basic vector were. Sequences for these oligonucleotides were shown below in the EMSA section.
Generation and expression of mutant TR proteins
The open reading frame of human TR1 cDNA (Hofmann et al., 1998) was PCR ampli®ed using the following primers. The 5' primer (forward), 5'-CGGAATTCGCCACCAT-GAACGGCCCTGAAGAT-3', included an EcoRI restriction site (bold face), a Kozak consensus sequence (italics) in the context of ®rst AUG codon and the coding region (underlined). The 3' primer (reverse), 5'-GGCCATGGGCAGC-CAGCCAGCCTGGAGGAT-3' consisted of a coding sequence and a KpnI site. This primer lacked the stop codon. Following ampli®cation (14 cycles) with AmpliTaq Gold (Perkin-Elmer Cetus Inc), the products were puri®ed, digested with EcoRI and KpnI, and subcloned into the mammalian expression vector pCXN2-myc. The myc-epitope tag is added to the carboxyl terminus of the expressed protein. The chicken actin promoter drives a high level expression of the transgene in this vector.
In the case of Cys mut PCR directed mutagenesis has resulted in the replacement of the`Cys-Val-Asn-Val-GlyCys' sequence with`Gly-Ala'. As a result four amino acids were lost in this mutant. The following primers were used for generating the Cys mut: Primer A: 5'-CCGGCGCCA-TACCTAAAAAACTGATGC-3'. Primer B: CCGGCGCC-TGTTTCCTCCGAGACCCC-3'. The NarI restriction sites in these oligonucleotides were shown in bold face. In the ®rst round of ampli®cation two PCR products were generated. In one reaction the 5' (forward) primer and Primer B and in the other Primer A and 3' (reverse) primer were used to generate PCR products, using the wild type GRIM-12 (TR) as a template. These PCR products were puri®ed and digested with EcoRI+NarI and NarI+KpnI, respectively. The two digested products were ligated to EcoRI and KpnI digested pCXN2-myc in a three-way ligation mix. All mutants were con®rmed by sequencing prior to their use in the experiments.
Death assays
Cell death was determined using the Annexin-V binding assays. Following treatment with the indicated agents, cells were stained using a commercially available kit (Trevigen Inc) per manufacturer's recommendation. Cells were incubated with FITC tagged Annexin-V and propidium iodide. FITCstained cells were considered as apoptotic and were quanti®ed using Becton-Dickinson¯uorescence activated cell sorter.
Cell death was also monitored in a transient assay. Since the transfection eciency is only around 20%, it is important to score for the transfected cells. Therefore, the CMV-bgalactosidase reporter gene was transfected along with the eector plasmids. This plasmid permits the detection of transfected cells after staining with X-gal. Brie¯y, cells were transfected with the indicated plasmids using the Lipofectamine plus reagent. Total amount of DNA transfected was kept to a maximum of 2 ± 4 mg, depending on the experiment. At the end of the experiment cells were stained with a commercially available in situ b-galactosidase detection kit, containing X-gal (Stratagene Inc) and the number of cells stained blue was determined microscopically. Blue colored cells with a¯at attached epithelial morphology were considered alive and those with a rounded and detached appearance were considered dead. Multiple ®elds were scanned and a total of 300 ± 400 cells were counted to obtain statistically signi®cant numbers. In separate experiments, cells were transiently transfected with various plasmids and then stained with FITC-annexin-V to detect the apoptotic cells by FACS analysis. In each case triplicate transfectants were measured.
Sub cellular fractionation
Mitochondrial and cytosolic fractions were prepared after homogenization of cells in ice-cold 20 mM HEPES, pH 7.4 buer containing 250 mM Sucrose, 10 mM KCl, 1.5 mM MgCl 2 , 1 mM EDTA, 1 mM Dithiothreitol, 1 mM -PMSF, and a commercially available protease inhibitor cocktail (Sigma) as described previously (Vander Heiden et al., 1997) . After centrifugation at 750 g for 10 min, the supernatant was centrifuged at 10 000 g for 25 min. The pellet suspended in the above buer was considered to be the mitochondrial fraction. The supernatant was further centrifuged at 100 000 g for 1 h and supernatant was collected and represented the cytosolic fraction. An aliquot from the initial lysate was saved for determining the total cytochrome c content.
Gene expression analyses
Northern, and Western blot analyses, transfection, bgalactosidase, luciferase assays. SDS ± PAGE analyses were performed as described in our earlier publications (Weihua et al., 1997) . The expression of speci®c mRNAs was quanti®ed using a Molecular Dynamics phosphorimager. Western blots quanti®ed using a Molecular Dynamics laser densitometer. Total amount of transfected DNA (1.5 mg) was kept constant by adding pBluescript SK + DNA, where required. In general, 0.2 mg of luciferase and 0.1 mg of p53 expression vector. Where indicated 0.3 mg of mutant or wild type Trx1 or TR were cotransfected. CMV b-galactosidase reporter (0.2 mg) was used as an internal control for normalizing variations in transfection eciency. Luciferase and b-galactosidase assays were performed as described in common laboratory manuals (Ausubel et al., 1994) .
Electrophoretic mobility shift assays (EMSA)
A double stranded oligonucleotide comprising a consensus p53-binding site, TACAGAACATGTCTAAGCATGCTG-GGG, end labeled with 32 P using T4 polynucleotide kinase. The p53-binding site is underlined. A mutant oligonucleotide with the CATG (shown in bold) changed to TCGC was used a competitor. Equal amounts of nuclear extracts were incubated with the labeled oligonucleotides in a binding reaction consisting of 50 mM HEPES, pH 7.5, 2 mg poly dI:dC, 50 mM KCl, 0.05 mM DTT and 10 mg BSA and 10% glycerol. The reaction products were separated on 6% polyacrylamide gel. Bands were detected after autoradiography. In the case of cold competition studies, nuclear extracts were incubated ®rst with 506 each of unlabeled wild type or mutant oligonucleotides for 10 min and then with the labeled probe. For antibody supershift analysis, nuclear extracts were preincubated in the absence or presence of a polyclonal antibody against p53 (4 ml) for 30 min at room temperature and then with the labeled probe.
Abbreviations
Cys mut: A TR-mutant lacking the active site cysteines; GRIM: gene associated with retinoid-IFN induced mortality; IFN: interferon; ORF: open reading frame; PIG: p53 inducible gene; RA: all trans retinoic acid; p53RE: p53 responsive element; TR: thioredoxin reductase; and Trx: thioredoxin. Trx mut: a mutant Trx1 lacking the critical cysteine residues
